Valerie Montgomery Rice to Humans
This is a "connection" page, showing publications Valerie Montgomery Rice has written about Humans.
Connection Strength
0.334
-
Montgomery Rice V, Elks ML, Howse M. The Supreme Court Decision on Affirmative Action-Fewer Black Physicians and More Health Disparities for Minoritized Groups. JAMA. 2023 09 19; 330(11):1035-1036.
Score: 0.043
-
Yancy CW, Barabino G, Bright C, Laurencin CT, Montgomery Rice V. The Supreme Court and the Importance of Diversity in Medicine. N Engl J Med. 2023 Aug 24; 389(8):677-679.
Score: 0.043
-
Montgomery Rice V. Diversity in Medical Schools: A Much-Needed New Beginning. JAMA. 2021 Jan 05; 325(1):23-24.
Score: 0.036
-
Montgomery Rice V. Giving "All" Babies a Great Start, Nutrition Matters. Breastfeed Med. 2018 10; 13(8):520-523.
Score: 0.031
-
Gangula PR, Dong YL, Al-Hendy A, Richard-Davis G, Montgomery-Rice V, Haddad G, Millis R, Nicholas SB, Moseberry D. Protective cardiovascular and renal actions of vitamin D and estrogen. Front Biosci (Schol Ed). 2013 01 01; 5(1):134-48.
Score: 0.021
-
Rice VM. Morehouse School of Medicine, Atlanta. J Med Assoc Ga. 2012; 101(1):14-5.
Score: 0.019
-
Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception. 2006 Aug; 74(2):90-9.
Score: 0.013
-
Rice VM. Strategies and issues for managing menopause-related symptoms in diverse populations: ethnic and racial diversity. Am J Med. 2005 Dec 19; 118 Suppl 12B:142-7.
Score: 0.013
-
Rice VM. Post menopausal hormone therapy today. Ethn Dis. 2005; 15(2 Suppl 2):S34-9.
Score: 0.012
-
Rice VM. Effect of moderate-intensity exercise in alleviating menopausal symptoms. Menopause. 2004 Jul-Aug; 11(4):372-4.
Score: 0.011
-
Rice VM. Optimizing the dose of hormone replacement therapy. Int J Fertil Womens Med. 2002 Sep-Oct; 47(5):205-10.
Score: 0.010
-
Rice VM. Conventional medical therapies for endometriosis. Ann N Y Acad Sci. 2002 Mar; 955:343-52; discussion 389-93, 396-406.
Score: 0.010
-
Montgomery Rice V. Hormone replacement therapy: optimising the dose and route of administration. Drugs Aging. 2002; 19(11):807-18.
Score: 0.010
-
Eltom SE, Tchounwou PB, Rice VM. Bringing new minds and new methods to bridging health disparity and equity. J Health Care Poor Underserved. 2011; 22(4 Suppl):3-4.
Score: 0.009
-
Carson SA, Eschenbach DA, Lomax G, Rice VM, Sauer MV, Taylor RN. Proposed oocyte donation guidelines for stem cell research. Fertil Steril. 2010 Dec; 94(7):2503-6.
Score: 0.008
-
Brown M, Ofili EO, Okirie D, Pemu P, Franklin C, Suk Y, Quarshie A, Mubasher M, Sow C, Montgomery Rice V, Williams D, Brooks M, Alema-Mensah E, Mack D, Dawes D. Morehouse Choice Accountable Care Organization and Education System (MCACO-ES): Integrated Model Delivering Equitable Quality Care. Int J Environ Res Public Health. 2019 08 25; 16(17).
Score: 0.008
-
Rida P, Ogden A, Ellis IO, Varga Z, Wolff AC, Traina TA, Hatzis C, Palmer JR, Ambrosone CB, Lehmann BD, Nanda R, Montgomery Rice V, Brawley OW, Torres MA, Rakha E, Aneja R. First international TNBC conference meeting report. Breast Cancer Res Treat. 2018 Jun; 169(3):407-412.
Score: 0.007
-
Son DS, Parl AK, Rice VM, Khabele D. Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells. Cancer Biol Ther. 2007 Aug; 6(8):1302-12.
Score: 0.007
-
Bigby JA, Caine VA, Rice VM. Plenary session 2: Improving quality. Making a difference at the individual, business, and community levels. Ethn Dis. 2005; 15(2 Suppl 2):S68-73.
Score: 0.006
-
Zhang D, Al-Hendy M, Richard-Davis G, Montgomery-Rice V, Rajaratnam V, Al-Hendy A. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil Steril. 2010 Oct; 94(5):1887-93.
Score: 0.004
-
Norris KC, Baker RS, Taylor R, Montgomery-Rice V, Higginbotham EJ, Riley WJ, Maupin J, Drew-Ivie S, Reede JY, Gibbons G. Historically black medical schools: addressing the minority health professional pipeline and the public mission of care for vulnerable populations. J Natl Med Assoc. 2009 Sep; 101(9):864-72.
Score: 0.004
-
Khabele D, Son DS, Parl AK, Goldberg GL, Augenlicht LH, Mariadason JM, Rice VM. Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. Cancer Biol Ther. 2007 May; 6(5):795-801.
Score: 0.003
-
Lobo RA, B?lisle S, Creasman WT, Frankel NR, Goodman NE, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Should symptomatic menopausal women be offered hormone therapy? MedGenMed. 2006; 8(2):1 p preceding 35.
Score: 0.003
-
Lobo RA, B?lisle S, Creasman WT, Frankel NR, Goodman NF, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Should symptomatic menopausal women be offered hormone therapy? MedGenMed. 2006; 8(3):40.
Score: 0.003